18VAC110-60-290. Labeling of batch of cannabis products.
A. Cannabis products produced as a batch shall not be adulterated.
B. Cannabis products produced as a batch shall be:
1. Processed, packaged, and labeled according to the U.S. Food and Drug Administration's Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, 21 CFR Part 111; and
2. Labeled with:
a. The name and address of the pharmaceutical processor;
b. The brand name of the cannabis product that was registered with the board pursuant to 18VAC110-20-285;
c. A unique serial number that matches the product with the pharmaceutical processor batch and lot number so as to facilitate any warnings or recalls the board or pharmaceutical processor deem appropriate;
d. The date of testing and packaging;
e. The expiration date, which shall be six months or less from the date of packaging, unless supported by stability testing;
f. The quantity of cannabis products contained in the batch;
g. A terpenes profile and a list of all active ingredients, including:
(1) Tetrahydrocannabinol (THC);
(2) Tetrahydrocannabinol acid (THC-A);
(3) Cannabidiol (CBD); and
(4) Cannabidiolic acid (CBDA).
For botanical cannabis products, only the total cannabidiol (CBD) and total tetrahydrocannabinol (THC) are required;
h. For cannabis oil products, pass or fail rating based on the laboratory's microbiological, mycotoxins, heavy metals, residual solvents, and pesticide chemical residue analysis; and
i. For botanical cannabis products, a pass or fail rating based on the laboratory's microbiological, mycotoxins, heavy metals, pesticide chemical residue analysis, water activity, and moisture content, and the potency.
Statutory Authority
§§ 54.1-3442.6 and 54.1-3447 of the Code of Virginia.
Historical Notes
Derived from Virginia Register Volume 35, Issue 23, eff. August 7, 2019; amended, Virginia Register Volume 37, Issue 1, eff. September 30, 2020; Volume 37, Issue 25, eff. September 1, 2021.